In the Atp7b−/− mouse model of WD, copper down-regulates lipid metabolism, particularly cholesterol biosynthesis [31], and patients with hepatic symptoms exhibit lower total cholesterol serum concentration than others [32]. This evidence concerns the gene ATP7B and Wilson disease.